Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Washington Legal Foundation

This article was originally published in The Gray Sheet

Executive Summary

April 6 motion requests that FDA be ordered to withdraw its March 16 Federal Register notice on off-label dissemination. The notice laid out FDA's interpretation of a Feb. 11 Washington, D.C. federal appeals court ruling vacating portions of a July 1999 decision by Washington D.C. district court Judge Royce Lamberth enjoining FDA from restricting dissemination of off-label information (1"The Gray Sheet" March 20, p. 6). The notice put FDA's "spin" on the appellate decision, suggesting that the agency "is no longer restricted by the court's injunction" although part of the injunction still stands, WLF says. The organization expects a decision by mid-summer

You may also be interested in...



WLF Will Use FDA Notice On Circuit Court Ruling As Wedge To Reopen Case

FDA's intention to use journal reprints distributed for off-label indications as evidence in misbranding enforcement actions violates the standing injunction on two "enduring materials" guidance documents, the Washington Legal Foundation contends.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel